Left ventricular isovolumic relaxation and renin-angiotensin system in the growth restricted fetus. 2008

Pavel B Tsyvian, and Tatiana V Markova, and Svetlana V Mikhailova, and Wim C J Hop, and Juriy W Wladimiroff
Mother and Child Care Institute, Yekaterinburg, Russia. p.tsyvian@iip.uran.ru

OBJECTIVE To determine left ventricular isovolumic relaxation time (LV IRT) in normally developing and growth restricted fetuses (FGR) as an indicator of fetal cardiac afterload and neonatal systolic blood pressure. METHODS A prospective longitudinal study in 124 normally developing and 47 growth restricted fetuses (FGR). LV IRT, fetal heart rate (FHR) and umbilical artery pulsatility index (PI) were determined at 2-3 week intervals starting at 22-26 weeks of gestation until delivery. Renin and angiotensin I levels were measured by radioimmunoassay in umbilical venous blood after delivery. Systolic blood pressure was measured at day 1 and day 5 of postnatal life. To evaluate the association between LV IRT, gestational age and FHR, bivariate regression analyses were performed. RESULTS Mean LV IRT (62+/-8 ms) was 29 percent longer in FGR as compared to the normal subset (47+/-6 ms) at all gestational ages (p<0.001). Mean postnatal active plasma renin level (7.78+/-S.D. 1.03 ng/ml) and postnatal angiotensin I level (4.21+/-0.70 ng/ml) in the FGR subset were significantly higher (p<0.001) than in the normal subset (4.81+/-1.04 ng/ml, renin and 2.69+/-0.44 ng/ml, angiotensin I). There was a significant difference (p<0.01) in systolic blood pressure between the two subsets on postnatal day 1 (FGR 52+/-6 mmHg vs. normal 46+/-4 mmHg) and day 5 (FGR 76+/-5 mmHg vs. normal 60+/-6 mmHg). CONCLUSIONS Left ventricular isovolumic relaxation time may act as a sensitive index of increased arterial afterload in the growth retarded fetus and may herald raised systolic blood pressure in the early neonatal period.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D005260 Female Females
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D005317 Fetal Growth Retardation Failure of a FETUS to attain expected GROWTH. Growth Retardation, Intrauterine,Intrauterine Growth Retardation,Fetal Growth Restriction,Intrauterine Growth Restriction
D006340 Heart Rate, Fetal The heart rate of the FETUS. The normal range at term is between 120 and 160 beats per minute. Fetal Heart Rate,Fetal Heart Rates,Heart Rates, Fetal,Rate, Fetal Heart,Rates, Fetal Heart

Related Publications

Pavel B Tsyvian, and Tatiana V Markova, and Svetlana V Mikhailova, and Wim C J Hop, and Juriy W Wladimiroff
January 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography,
Pavel B Tsyvian, and Tatiana V Markova, and Svetlana V Mikhailova, and Wim C J Hop, and Juriy W Wladimiroff
June 1990, Acta paediatrica Japonica : Overseas edition,
Pavel B Tsyvian, and Tatiana V Markova, and Svetlana V Mikhailova, and Wim C J Hop, and Juriy W Wladimiroff
May 1996, The American journal of cardiology,
Pavel B Tsyvian, and Tatiana V Markova, and Svetlana V Mikhailova, and Wim C J Hop, and Juriy W Wladimiroff
August 2000, Medicine and science in sports and exercise,
Pavel B Tsyvian, and Tatiana V Markova, and Svetlana V Mikhailova, and Wim C J Hop, and Juriy W Wladimiroff
June 1985, Journal of cardiography,
Pavel B Tsyvian, and Tatiana V Markova, and Svetlana V Mikhailova, and Wim C J Hop, and Juriy W Wladimiroff
June 2009, Current hypertension reports,
Pavel B Tsyvian, and Tatiana V Markova, and Svetlana V Mikhailova, and Wim C J Hop, and Juriy W Wladimiroff
September 1973, Circulation,
Pavel B Tsyvian, and Tatiana V Markova, and Svetlana V Mikhailova, and Wim C J Hop, and Juriy W Wladimiroff
April 1978, Israel journal of medical sciences,
Pavel B Tsyvian, and Tatiana V Markova, and Svetlana V Mikhailova, and Wim C J Hop, and Juriy W Wladimiroff
September 1995, Polskie Archiwum Medycyny Wewnetrznej,
Pavel B Tsyvian, and Tatiana V Markova, and Svetlana V Mikhailova, and Wim C J Hop, and Juriy W Wladimiroff
January 1997, Advances in experimental medicine and biology,
Copied contents to your clipboard!